Home > Journals > Minerva Medica > Past Issues > Articles online first > Minerva Medica 2021 Sep 03

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

Minerva Medica 2021 Sep 03

DOI: 10.23736/S0026-4806.21.07716-8

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

BRD7 increases resistance to EGFR tyrosine kinase inhibitor (EGFR-TKI) in non-small cell lung cancer

Haiping ZHANG 1, Li ZHANG 2, Jianfang XU 1

1 Department of Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China; 2 Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China


PDF


top of page